NO304654B1 - Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell - Google Patents

Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell

Info

Publication number
NO304654B1
NO304654B1 NO960741A NO960741A NO304654B1 NO 304654 B1 NO304654 B1 NO 304654B1 NO 960741 A NO960741 A NO 960741A NO 960741 A NO960741 A NO 960741A NO 304654 B1 NO304654 B1 NO 304654B1
Authority
NO
Norway
Prior art keywords
preparing
host cell
recombinant vector
therapeutically active
active polypeptide
Prior art date
Application number
NO960741A
Other languages
Norwegian (no)
Other versions
NO960741D0 (en
NO960741L (en
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1990/001348 external-priority patent/WO1990011089A1/en
Application filed by Chiron Corp filed Critical Chiron Corp
Priority to NO960741A priority Critical patent/NO304654B1/en
Publication of NO960741D0 publication Critical patent/NO960741D0/en
Publication of NO960741L publication Critical patent/NO960741L/en
Publication of NO304654B1 publication Critical patent/NO304654B1/en

Links

NO960741A 1989-03-17 1996-02-23 Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell NO304654B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO960741A NO304654B1 (en) 1989-03-17 1996-02-23 Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US32533889A 1989-03-17 1989-03-17
US34133489A 1989-04-20 1989-04-20
US35500289A 1989-05-18 1989-05-18
PCT/US1990/001348 WO1990011089A1 (en) 1989-03-17 1990-03-15 Nanbv diagnostics and vaccines
NO904712A NO303941B1 (en) 1989-03-17 1990-10-30 Essentially isolated polypeptide for use in detecting antibody to HCV in vitro and in an in vitro immunoassay, immunoassay and antibody composition
NO960741A NO304654B1 (en) 1989-03-17 1996-02-23 Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell

Publications (3)

Publication Number Publication Date
NO960741D0 NO960741D0 (en) 1996-02-23
NO960741L NO960741L (en) 1996-02-23
NO304654B1 true NO304654B1 (en) 1999-01-25

Family

ID=27532599

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960741A NO304654B1 (en) 1989-03-17 1996-02-23 Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell

Country Status (1)

Country Link
NO (1) NO304654B1 (en)

Also Published As

Publication number Publication date
NO960741D0 (en) 1996-02-23
NO960741L (en) 1996-02-23

Similar Documents

Publication Publication Date Title
DE3463510D1 (en) (21-leucine) human urogastrone, corresponding gene, corresponding recombinant plasmid, transformed cell and process for production thereof
ATA257190A (en) VIRAL POLYPEPTIDE
EP0524260A4 (en) Gpib-g(a) fragments and recombinant dna expression vectors
ZA896715B (en) Fusion protein of paramyxovirus,method of production using recombinant baculovirus expression vector,vaccine comprising such protein and use thereof
DK151985A (en) HUMANT PHYSIOLOGICALLY ACTIVE POLYPEPTIDE
GB9015494D0 (en) Active polarization control servo and method
NO842962L (en) PROCEDURE FOR PREPARING A POLYPEPTIDE SUITABLE FOR USE IN A VACCINATION PROCEDURE
EP0437610A4 (en) Novel physiologically active polypeptide, recombinant plasmid, recombinant microbial cells, medicinal composition, and process for recovering purified polypeptide
GB2162851B (en) Novel b-urogastrone gene, corresponding recombinant plasmids, corresponding transformants and preparations thereof and of b-urogastrone.
DK354389D0 (en) POLYPEPTIDE
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
AU4665193A (en) A process for recovering a recombinant protein, in biologically active form, from a solution containing inactive protein
NO891006D0 (en) THERAPEUTIC ACTIVE POLYPEPTID AND PROCEDURE FOR ITS PREPARATION.
DK326889A (en) POLYPEPTIDE AND POLYPEPTIDE COMPLEX AND THEIR USE
NO902871D0 (en) PROCEDURE FOR INTRODUCING A PEPTIDE IN CYTOSOL.
ZA897633B (en) Recombinant pdgf and methods for production
NZ239948A (en) Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160
HU9200088D0 (en) Recombinant process for producing hirudine and hirudinelike new polypeptides
NO176105C (en) Analogous Process for Preparing Therapeutically Active Peptide Derivatives
DE3886517D1 (en) Human prourokinase-like polypeptide.
NO304654B1 (en) Process for Preparing a Therapeutically Active Polypeptide, Recombinant Vector and Host Cell
DK426585A (en) PROCEDURE FOR EXPRESSING A FUNCTIONAL POLYPEPTIDE IN BACILLUS AND VECTOR FOR USING THE PROCEDURE
EP0170266A3 (en) Process for producing protein, and vector, recombinant dna and transformant used therefor
DK429485A (en) PROCEDURE FOR EXPRESSING A FUNCTIONAL POLYPEPTIDE IN STREPTOMYCES AND VECTOR FOR USING THE PROCEDURE
PT87207A (en) PROCESS FOR PREPARING RECOMBINANT HTLV-III PROTEINS AND USES THEREOF

Legal Events

Date Code Title Description
MK1K Patent expired